Additional renal and systemic parameters of inflammation and oxidative stress including renal blood flow may be useful to uncover mechanism(s) related to benefits of SGLT‐2 inhibition in SCD. The gene discussed is SLC5A2; the disease is Schnyder corneal dystrophy.